AHD International, Importer and Distributor of Nutraceutical Ingredients

Anti-Oxidants & Immune Enhancing Ingredients

Cardiovascular Health

Ingredients for Healthy Joints and Cartilage

Memory & Mental Enhancing Ingredients

Menopause and Women's Health

Mood and Emotional Health

Weight Loss

All Natural Products

Product Infomation

Nutraceutical News
Clinical Studies



What's Hot?
Collagen Bulk Sales
Hoodia Bulk Sales
Hyaluronic Acid
Who We Are
About AHD
Contact AHD

Fucoidan Clinical Study

Fucoidan extracted from Cladosiphon okamuranus Tokida induces apoptosis of human T-cell leukemia virus type 1-infected T-cell lines and primary adult T-cell leukemia cells.

Haneji K, Matsuda T, Tomita M, Kawakami H, Ohshiro K, Uchihara JN, Masuda M, Takasu N, Tanaka Y, Ohta T, Mori N.

Division of Molecular Virology and Oncology, Graduate School of Medicine, University of the Ryukyus, Nishihara, Okinawa, Japan.

Adult T-cell leukemia (ATL) is caused by human T-cell leukemia virus type 1 (HTLV-1) and remains incurable. The highest endemic area of HTLV-1 carriers in Japan is located in Okinawa, and novel treatments are urgently needed in this area. We extracted fucoidan, a sulfated polysaccharide, from the brown seaweed Cladosiphon okamuranus Tokida cultivated in Okinawa, Japan and examined its tumor-suppression activity against ATL. Fucoidan significantly inhibited the growth of peripheral blood mononuclear cells of ATL patients and HTLV-1-infected T-cell lines but not that of normal peripheral blood mononuclear cells. Fucoidan induced apoptosis of HTLV-1-infected T-cell lines mediated through downregulation of cellular inhibitor of apoptosis protein-2 and survivin and G1 phase accumulation through the downregulation of cyclin D2, c-myc, and hyperphosphorylated form of the retinoblastoma tumor suppressor protein. Further analysis showed that fucoidan inactivated NF-kappaB and activator protein-1 and inhibited NF-kappaB-inducible chemokine, C-C chemokine ligand 5 (regulated on activation, normal T expressed and secreted) production, and homotypic cell-cell adhesion of HTLV-1-infected T-cell lines. In vivo use of fucoidan resulted in partial inhibition of growth of tumors of an HTLV-1-infected T-cell line transplanted subcutaneously in severe combined immune deficient mice. Our results indicate that fucoidan is a potentially useful therapeutic agent for patients with ATL.

PMID: 16201850 [PubMed - indexed for MEDLINE]

<< Back to Aloe Vera Clinical Study List

We are strictly a bulk supplier to manufacturers – we do not sell to re-sellers or individuals. Our minimum order size is approximately 25 kilos. We are one of only a few suppliers that carry $5 million product liability insurance for our customers. AHD International LLC is classified as a importer, exporter, manufacturer, distributor of nutritional ingredients depending on the ingredient specified. AHD has 5 warehouse locations across North America and sales agents in over 10 countries. We are the only ingredient company to be awarded the Dun and Bradstreet's fastest growing company in America twice in 1999 and 2002.

For quotes please click here

*"These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease."

© AHD International, LLC.
Legal and Privacy Statement

Entrepeneur Hot 100

Named in Dun & Bradstreet Entrepreneur Magazine "Hot 100" fastest growing companies.
For Vendors

Get a Quote
Partner With Us

Choose AHD

AHD has over 650 customers.

5 North American warehouses making large quantity orders and quick delivery possible.

Representatives in USA, Mexico, Chile, Brazil and Uruguay.

AHD has a reputation for carrying the highest quality products in the industry.

Exclusivity of premium products from some of the top nutraceutical companies world. wide.


Industry News
Business News
Food & Beverage
Sports Nurtition